Familial adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC): A review of clinical, genetic and therapeutic aspects

Schweizerische Medizinische Wochenschrift

Volumn 127, Issue 16, 1997, Pages 682-690

  Soravia, C ^a   Bapat, B ^a   Cohen, Z ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOSOMAL DOMINANT INHERITANCE; CLINICAL FEATURE; COLON RESECTION; COLORECTAL CANCER; DNA REPAIR; FAMILIAL POLYPOSIS; HUMAN; PROPHYLAXIS; REVIEW; TUMOR SUPPRESSOR GENE;

ADENOMATOUS POLYPOSIS COLI; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; GENES, APC; GENETIC COUNSELING; HUMANS; POINT MUTATION;

EID: 0030988351     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (118)

1. Miyaki M, Tanaka K, Kikichi-Yanoshita R, Muraoka M, Konishi M: Familial polyposis: recent advances. Crit Rev Oncol Hematol 1995; 19: 1-31.
2. de la Chapelle A, Peltomäki P: Genetics of hereditary colon cancer. Annu Rev Genet 1995; 29: 329-348.
3. Stella A, Resta N, Gentile M, Susca F, Mareni C et al.: Exclusion of the APC gene as the cause of a variant form of familial adenomatous polyposis (FAP). Am J Hum Genet 1993; 53: 1031-1037.
4. Thomas H, Whitelaw S, Cottrell S, Murday V, Tomlinson I et al.: Genetic mapping of the hereditary mixed polyposis syndrome to chromosome 6q. Am J Hum Genet 1996; 58: 770-776.
5. Jeevaratnam P, Cottier D, Browett P, van de Water N, Pokos V, Jass J: Familial giant hyperplastic polyposis predisposing to colorectal cancer: a new hereditary bowel cancer syndrome. J Pathol 1996; 179: 20-25.
6. Lewis C, Neuhausen S, Daley D, Black F, Swensen J et al.: Genetic heterogeneity and unmappend genes for colorectal cancer. Cancer Res 1996; 56: 1382-1388.
7. Kinzler K, Vogelstein B: Lessons from hereditary colorectal cancer. Cell 1996; 87: 159-170.
8. Weber W, Mulvihill J, Narod S: Familial cancer management. Boca Raton: CRC Press, 1996.
9. Bussey H: Familial polyposis coli. Families studies, histopathology, differential diagnosis, and results of treatment. Baltimore: The John Hopkins Yale University Press, 1975.
10. Gardner EJ: A genetic and clinical study of intestinal polyposis, a predisposing factor for carcinoma of the colon and rectum. Am J Hum Genet 1951; 3: 167-176.
11. Phillips RKS, Spigelman AD, Thomson JP: Familial adenomatous polyposis and other polyposis syndromes. London: Edward Arnold, 1994.
12. Sarre RG, Frost AG, Jagelman DG, Petras RE, Sivak MV, McGannon E: Gastric and duodenal polyps in familial adenomatous polyposis: a prospective study of the nature and prevalence of upper gastrointestinal polyps. Gut 1987; 28: 306-314.
13. Church J, McGannon E, Hull-Boiner S, Sivak MV, Van Stolk R et al.: Gastroduodenal polyps in patients with familial adenomatous polyposis. Dis Colon Rectum 1992; 35: 1170-1173.
14. Giardiello FM, Offerhaus GJA, Krush AJ, Booker SV, Tersmette AC et al.: Risk of hepatoblastoma in familial adenomatous polyposis. J Pediatr 1991; 119: 766-768.
15. Jones IT, Fazio VW, Weakley FL, Jagelman DG, Lavery IC, McGannon E: Desmoid tumours in familial polyposis coli. Ann Surg 1986; 204: 94-97.
16. Gurbuz AK, Giardiello FM, Petersen GM, Krush AJ, Offerhaus GJA et al.: Desmoid tumours in familial adenomatous polyposis. Gut 1994; 35: 377-381.
17. Giardiello F, Offerhaus G, Lee D, Krush A, Tersmette A et al.: Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut 1993; 34: 1394-1396.
18. Sondergaard JO, Rasmussen MS, Videbeaek H, Bernstein IT, Myrhoj T et al.: Mandibular osteomas in sporadic colorectal carcinoma. A genetic marker. Scand J Gastroenterol 1993; 28: 23-24.
19. Blair NP, Trempe CL: Hypertrophy of the retinal pigment epithelium associated with Gardner's syndrome. Am J Ophthalmology 1980; 90: 661-667.
20. Traboulsi EI, Krush AJ, Gardner EJ, Booker SV, Offerhaus GL et al.: Prevalence and importance of pigmented ocular fundus lesions in Gardner's syndrome. N Engl J Med 1987; 316: 661-667.
21. Chapman PD, Church W, Burn J, Gunn A: Congenital hypertrophy of retinal pigment epithelium: a sign of familial adenomatous polyposis. Br Med J 1989; 298: 353-354.
22. Schneider NR, Cubilla AL, Chaganti RSK: Association of endocrine neoplasia with multiple polyposis of the colon. Cancer 1983; 51: 1171-1175.
23. Turcot J, Deprés JP, Pierre FS: Malignant tumors of the central nervous system associated with familial polyposis of the colon: report of two cases. Dis Colon Rectum 1959; 2: 465-468.
24. Kropilak M, Jagelman DG, Fazio VW, Lavery IL, McGannon E: Brain tumors in familial adenomatous polyposis. Dis Colon Rectum 1989; 32: 778-782.
25. Itoh H, Hirata K, Ohsato K: Turcot's syndrome and familial adenomatous polyposis associated with brain tumor: review of related literature. Int J Colorectal Dis 1993; 8: 87-94.
26. Lynch HT, Smyrk T, McGinn T, Lanpsa S, Cavalieri J et al.: Attenuated familial adenomatous polyposis (AFAP). A phenotypically and genotypically distinctive variant of FAP. Cancer 1995; 76: 2427-2433.
27. Leppert M, Dobbs M, Scambler P, O'Connell P, Nakamura Y et al.: The gene for familial polyposis coli maps to the long arm of chromosome 5. Science 1987; 238: 1411-1413.
28. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L et al.: Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991; 66: 589-600.
29. Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM et al.: Identification of FAP locus genes from chromosome 5q21. Science 1991; 253: 661-665.
30. Varesco L, Gismondi V, Presciuttini S, Groden J, Spirio L et al.: Mutation in a splice-donor site of the APC gene in a family with polyposis and late age of colonie cancer death. Hum Genet 1994; 93: 281-286.
31. van der Luijt R, Vasen H, Tops C, Breukel C, Fodde R, Meera Khan P: APC mutation in the alternatively spliced region of exon 9 associated with late onset familial adenomatous polyposis. Hum Genet 1995; 96: 705-710.
32. Samowitz WS, Thliveris A, Spirio LN, White R: Alternatively spliced adenomatous polyposis coli (APC) gene transcripts that delete exons mutated in attenuated APC. Cancer Res 1995; 55: 3732-3734.
33. Xia L, St Denis K, Bapat B: Evidence for a novel exon in the coding region of the adenomatous polyposis coli (APC) gene. Genomics 1995; 28: 589-591.
34. Béroud C, Soussi T: APC gene: database of germline and somatic mutations in human tumors and cell lines. Nucleic Acids Res 1996; 24: 121-124.
35. Nagase H, Nakamura Y: Mutations of the APC (adenomatons polyposis coli) gene. Hum Mut 1993; 2: 425-434.
36. Nakamura Y: The role of the adenomatous polyposis coli (APC) gene in human cancers. Adv Cancer Res 1993; 62: 65-87.
37. Powell SM, Petersen GM, Krush AJ, Booker SV, Jen J et al.: Molecular diagnosis of familial adenomatous polyposis. N Engl J Med 1993; 329: 1982-1987.
38. Bala S, Kraus C, Wijinen J, Meera Khan P, Ballhausen W: Multiple products in the protein truncation test due to alternative splicing in the adenomatous polyposis coli (APC) gene. Hum Genet 1996; 98: 528-533.
39. Knudson AG Jr: Hereditary cancer, oncogenes, and antioncogenes. Cancer Res 1985; 45: 1437-1443.
40. Giardiello FM, Krush AJ, Petersen GM, Booker SV, Kerr M et al.: Phenotypic variability of familial adenomatous polyposis in 11 unrelated families with identical APC gene mutation. Gastroenterology 1994; 106: 1542-1547.
41. Olschwang S, Tiret A, Laurent-Puig P, Muleris M, Parc R, Thomas G: Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients. Cell 1993; 75: 959-968.
42. Nagase H, Miyoshi Y, Horii A, Ogawa M, Utsunomiya J et al.: Correlation between the location of germ-line mutations in the APC gene and the number of colorectal polyps in familial adenomatous polyposis patients. Cancer Res 1992; 52: 4055-4057.
43. Gayther S, Wells D, SenGupta S, Chapman P, Neale K et al.: Regionally clustered APC mutations are associated with a severe phenotype and occur at a high frequency in new mutation cases of adenomatous polyposis coli. Hum Mol Genet 1994; 3: 53-56.
44. Spirio L, Olschwang S, Groden J, Robertson M, Samowitz W et al.: Alleles of the APC gene: an attenuated form of familial polyposis. Cell 1993; 75: 951-957.
45. Olschwang S, Laurent-Puig P, Groden J, White R, Thomas G: Germ-line mutations in the first 14 exons of the adenomatous polyposis coli (APC) gene. Am J Hum Genet 1993; 52: 273-279.
46. Dobbie Z, Spycher M, Hürliman R, Ammann R, Amman T et al.: Mutational analysis of the first 14 exons of the adenomatous polyposis coli (APC) gene. Eur J Cancer 1994; 30: 1709-1713.
47. Friedl W, Meuschel S, Caspari R, Lamberti C, Krieger S et al.: Attenuated familial adenomatous polyposis due to a mutation in the 3' part of the APC gene. A clue for understanding the function of the APC protein. Hum Genet 1996; 97: 579-584.
48. Hamilton S, Liu B, Parsons RE, Papadopoulos N, Jen J et al.: The molecular basis of Turcot's syndrome. N Engl J Med 1995; 332: 839-849.
49. Su LK, Vogelstein B, Kinzler KW: Association of the APC tumor suppressor protein with catenins. Science 1993; 262: 1734-1737.
50. Polakis P: Mutations in the APC gene and their implications for protein structure and function. Current Opinion Genet Develop 1995; 5: 66-71.
51. Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P: Binding of GSK3β to the APC-β-catenin complex and regulation of complex assembly. Science 1996; 272: 1023-1026.
52. Matsumine A, Ogai A, Senda T, Okumura N, Satoh K et al.: Binding of APC to the human homolog of the drosophila discs large tumor suppressor protein. Science 1996; 272: 1020-1023.
53. Berk T, Cohen Z, Cullen J: Familial polyposis and the role of the preventive registry. Can Med Assoc J 1981; 124: 1427-1428.
54. Tamura K, Yamamoto Y, Saeki Y, Furuyama JI, Utsunomiya J: Simple, rapid, and accurate determination of deletion mutations by automated DNA sequencing of heteroduplex fragments of the adenomatous polyposis coli (APC) gene generated by PCR amplification. Hum Mut 1993; 2: 478-484.
55. Mandl M, Pfaffenholz R, Friedl W, Caspari R, Sengteller M, Propping P: Frequency of common and novel inactivating APC mutations in 202 families with familial adenomatous polyposis. Hum Mol Genet 1994; 3: 181-184.
56. Soravia C, Kartheuser A, Ayala T, Detry R, Hoang P et al.: L'anastomose iléo-anale dans la rectocolite ulcéro-hémorragique et la polypose adénomateuse familiale: faut-il faire une mucosectomie endo-anale de principe? Gastroenterol Clin Biol 1994; 18: 469-474.
57. Dozois RR, Kelly KA, Welling DR, Gordon H, Beart RW et al.: Ileal pouch-anal anastomosis: comparison of results in familial adenomatous polyposis and chronic ulcerative colitis. Ann Surg 1989; 210: 268-273.
58. Kartheuser A, Parc R, Penna C, Tiret E, Frileux P et al.: Ileal pouch-anal anastomosis as the first choice operation in patients with familial adenomatous polyposis: a ten-year experience. Surgery 1996; 119: 615-623.
59. Nugent K, Phillips R: Rectal cancer risk in older patients with familial adenomatous polyposis and an ileorectal anastomosis: a cause for concern. Br J Surg 1992; 79: 1204-1206.
60. Vasen H, van der Luijt R, Slors J, Buskens E, de Ruiter P et al.: Molecular genetic tests as a guide to surgical management of familial adenomatous polyposis. Lancet 1996; 348: 433-435.
61. Belchetz L, Berk T, Bapat B, Cohen Z, Gallinger S: Changing causes of mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 1996; 39: 384-387.
62. Sanabria JR, Croxford R, Berk TC, Cohen Z, Bapat BV, Gallinger S: Familial segregation in the occurrence and severity of periampullary neoplasms in familial adenomatous polyposis. Am J Surg 1996; 171: 136-141.
63. Nugent K, Spigelman A, Phillips R: Risk of extracolonic cancer in familial adenomatous polyposis. Br J Surg 1996; 83: 1121-1122.
64. Soravia C, Berk T, Haber G, Cohen Z, Gallinger S: An aggressive approach to advanced duodenal polyposis in familial adenomatous polyposis. Gastroenterology 1996; 110: A596.
65. Giardiello F, Offerhaus J: Phenotype and cancer risks of various polyposis syndromes. Eur J Cancer 1995; 31A: 1085-1087.
66. Penna C, Tiret E, Parc R, Sfairi A, Kartheuser A et al.: Operation and abdominal desmoid tumors in familial adenomatous polyposis. Surg Gynecol Obstet 1993; 177: 263-268.
67. Rodrigues-Bigas MA, Mahonney MC, Karakousis CP, Petrelli NJ: Desmoids tumors in patients with familial adenomatous polyposis. Cancer 1994; 74: 1270-1274.
68. Warthin A: Heredity with reference to carcinoma. Arch Intern Med 1913; 12: 546-555.
69. Lynch H, Lynch P, Pester J, Fusaro R: The cancer family syndrome: rare cutaneous phenotypic linkage of Torre's syndrome. JAMA 1981; 141: 607-611.
70. Lynch HT, Smyrk T, Watson P, Lanspa SJ, Lynch JF et al.: Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 1993; 104: 1535-1549.
71. Lynch HT, Smyrk T: Hereditary nonpolyposis colorectal cancer (Lynch syndrome). Cancer 1996; 78: 1149-1167.
72. Watson P, Lynch H: Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 1993; 71: 677-685.
73. Risinger J, Barrett J, Watson P, Lynch H, Boyd J: Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome. Cancer 1996; 77: 1836-1843.
74. Fante R, Roncucci L, Di Gregorio C, Tamassia M, Losi L et al.: Frequency and clinical features of multiple tumors of the large bowel in the general population and in patients hereditary colorectal carcinoma. Cancer 1996; 77: 2013-2021.
75. Soravia C, Egeli R, Obradovic M, Ambrosetti P, Marti M et al.: Les tumeurs multiples du colon et du rectum. Schweiz Med Wochenschr 1993; 123: 570-572.
76. Vasen HFA, Mecklin JP, Meeran Khan P, Lynch HT: The international collaborative groupe on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum 1991; 34: 424-425.
77. Madlensky L, Berk T, Bapat B, McLeod R, Couture J et al.: A preventive registry for hereditary nonpolyposis colorectal cancer. Can J Oncol 1995; 5: 355-360.
78. Jass J, Stewart S: Evolution of hereditary non-polyposis colorectal cancer. Gut 1992; 33: 783-786.
79. Aarnio M, Mecklin J, Aaltonen L, Nyström-Lathi M, Järvinen H: Life-time risk of different cancers in hereditary nonpolyposis colorectal cancer (HPCC) syndrome. Int J Cancer 1995; 64: 430-433.
80. Muir G, Bell A, Barlow K: Multiple primary carcinomata of the colon, duodenum, and larynx associated with keratoacamhomata of the face. Br J Surg 1967; 54: 191-195.
81. Torre D: Multiple sebaceous tumors. Arch Dermatol 1968; 98: 549-551.
82. Fishel R, Lescoe M, Rao M, Copeland N, Jenkins N et al.: The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993; 75: 1027-1038.
83. Leach F, Nicolaides N, Papadopoulos N, Liu B, Jen J et al.: Mutations of a MutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993; 75: 1215-1225.
84. Papadopoulos N, Nicolaides NC, Wei YF, Ruben SM, Carter KC et al.: Mutation of a mutL homolog in hereditary colon cancer. Science 1994; 263: 1625-1629.
85. Bronner C, Baker S, Morrison P, Warren G, Smith L et al.: Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 1994; 368: 258-261.
86. Nicolaides NC, Papadopoulos N, Liu B, Wei YW, Carter KC et al.: Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994; 371: 75-80.
87. Kolodner RD: Mismatch repair: mechanisms and relationship to cancer susceptibility. Trends Biochem Sci 1995; 20: 397-401.
88. Rhyu M: Molecular mechanisms underlying hereditary nonpolyposis colorectal carcinoma. J Natl Cancer Inst 1996; 88: 240-251.
89. Thibodeau SN, Bren G, Schaid D: Microsatellite instability in cancer of the proximal colon. Science 1993; 260: 816-819.
90. Eshleman J, Markowitz S: Mismatch repair defects in human carcinogenesis. Hum Mol Genet 1996; 5: 1489-1494.
91. Liu B, Parsons R, Papadopoulos N, Nicolaides NC, Lynch HT et al.: Analysis of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients. Nature Med 1996; 2: 169-174.
92. Shibata D, Peinado MA, Ionov Y, Malkhosyan S, Perucho M: Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation. Nature Genet 1994; 6: 273-281.
93. Ionov Y, Peinado MA, Malkhosan S, Shibata D, Perucho M: Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993; 363: 558-561.
94. Liu B, Nicolaides N, Markowitz S, Willson J, Parsons R et al.: Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nature Genet 1995; 9: 48-55.
95. Peltomäki P, Lothe RA, Aaltonen LA, Pylkkänen L, Nyström-Lahti M et al.: Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome. Cancer Res 1993; 53: 5853-5855.
96. Buerstedde J, Alday P, Torhorst J, Weber W, Müller H, Scott R: Detection of new mutations in six out of 10 Swiss HNPCC families by genomic sequencing of the hMSH2 and hMLH1 genes. J Med Genet 1995; 32: 909-912.
97. Miyaki M, Konishi M, Muraoka M, Kikuchi-Yanoshita R, Tanaka K et al.: Germline mutations of hMSH2 and hMLH1 genes in Japanese families with hereditary non-polyposis colorectal cancer (HNPCC): usefulness of DNA analysis for screening and diagnosis of HNPCC patients. J Mol Med 1995; 73: 515-520.
98. Nyström-Lathi M, Wu Y, Moisio A, Hofstra R, Osinga J et al.: DNA mismatch repair gene mutations in 55 kindreds with verified or putative hereditary non-polyposis colorectal cancer. Hum Mol Genet 1996; 5: 763-769.
99. Hutter P, Couturier A, Scott R, Alday P, Delozier-Blanchet C et al.: Complex genetic predisposition to cancer in an extended HNPCC family with an ancestral hMLH1 mutation. J Med Genet 1996; 33: 636-640.
100. Luce M, Marra G, Chauhan D, Laghi L, Carethers J et al.: In vitro transcription/translation assay for the screening of hMLH1 and MSH2 mutations in familial colon cancer. Gastroenterology 1995; 109: 1368-1374.
101. Froggatt N, Brassett C, Koch D, Evans D, Hodgson S et al.: Mutation screening of MSH2 and MLH1 mRNA in hereditary non-polyposis colon cancer syndrome. J Med Genet 1996; 33: 726-730.
102. Kohonen-Corish M, Ross V, Doe W, Kool D, Edkins E et al.: RNA-based mutation screening in hereditary non-polyposis colorectal cancer. Am J Hum Genet 1996; 59: 818-824.
103. Xia L, Shen W, Ritacca F, Mitri A, Madlensky L et al.: A truncated hMSH2 transcript occurs as a common variant in the population: implications for genetic diagnosis. Cancer Res 1996; 56: 2289-2292.
104. Honchel R, Halling K, Schaid D, Pittelkow M, Thibodeau S: Microsatellite instability in Muir-Torre syndrome. Cancer Res 1994; 54: 1159-1163.
105. Kolodner R, Hall N, Lipford J, Kane M, Rao M et al.: Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for MSH2 mutations. Genomics 1994; 24: 516-526.
106. Bapat B, Xia L, Madlensky L, Mitri A, Narod S, Gallinger S: The genetic basis of Muir-Torre syndrome includes the hMLH1 locus. Am J Hum Genet 1996; 59: 736-739.
107. Vasen H, Wijnen J, Menko F, Kleibeuker J, Taal B et al.: Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996; 110: 1020-1027.
108. Sankila R, Aaltonen L, Järvinen H, Mecklin J: Better survival rates in patients with MLH1-associated hereditary colorectal cancer. Gastroenterology 1996; 110: 682-687.
109. Marra G, Boland CR: Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J Natl Cancer Inst 1995; 87: 1114-1125.
110. Järvinen H, Mecklin J, Sistonen P: Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 1995; 108: 1405-1411.
111. Weber T: Clinical surveillance recommendations adopted for HNPCC. Lancet 1996; 348: 465.
112. Lynch HT: Is there a role for prophylactic subtotal colectomy among hereditary nonpolyposis colorectal cancer germline mutation carriers? Dis Colon Rectum 1996; 39: 109-110.
113. Rodriguez-Bigas M: Prophylactic colectomy for gene carriers in hereditary nonpolyposis colorectal cancer. Cancer 1996; 78: 199-201.
114. Lerman C, Marshall J, Audrian J, Gomez-Caminero A: Genetic testing for colon cancer susceptibility: anticipated reactions of patients and challenges to providers. Int J Cancer 1996; 69: 58-61.
115. Lynch HT, Smyrk T, Lynch J, Lanspa S, McGinn T, Cavalieri R: Genetic counseling in an extended attenuated familial adenomatous polyposis kindred. Am J Gastroenterol 1996; 91: 455-459.
116. Albers D, Lipkin M, Levin B: Genetic screening for colorectal cancer and intervention. Int J Cancer 1996; 69: 62-63.
117. MacPhee M, Chepenik KP, Liddell RA, Nelson KK, Siracusa LD, Buchberg AM: The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of APC-Min induced intestinal neoplasia. Cell 1995; 81: 957-966.
118. Reitmair A, Cai J, Bjerknes M, Redston M, Cheng H et al.: MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorgenesis. Cancer Res 1996; 56: 2911-2926.